Delivery Order SPE2DR25D3012-SPE2DR26F4F5N
Award Date 1/23/26
Potential Completion Date 1/26/26
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,503.49 for 500 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory medication. This non-set-aside, firm fixed price delivery order was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a typical transactional purchase under the company's...
- The Defense Logistics Agency awarded a $1,512.46 delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 100 mg, a nonsteroidal anti-inflammatory medication. This firm fixed-price contract, with an ultimate completion date of July 1, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was competitively awarded without...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Celecoxib 200mg in quantities of 500 on January 23, 2026, by the Defense Logistics Agency (DLA). This firm fixed-price, competitively awarded contract has a ceiling value of $1,012.86 with an ultimate completion date of February 20, 2026. The delivery order was placed under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical...
- This delivery order, valued at $8,663.41, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for Celebrex 200 mg capsules in unit dose packaging (100 count). The contract was awarded on January 8, 2026, with an ultimate completion date of January 9, 2026, and carries no set-aside designation, indicating it was competitively awarded. The Defense Logistics Agency, under its medical supply chain operations, is the funding federal agency, and performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,357.88 to AmerisourceBergen Drug Corp for the supply of Celebrex 200 mg capsules (unit dose, 100 count) on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Celebrex 200 mg capsule in unit dose packaging (100 count) under a firm fixed-price contract valued at $4,985.13. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency awarded a delivery order valued at $1,302.42 to AmerisourceBergen Drug Corp for 100 capsules of Celebrex 200 mg on November 5, 2025, with completion scheduled for November 6, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- This delivery order, awarded on July 28, 2025, to AmerisourceBergen Drug Corp provides for the supply of Celebrex 200 mg capsules (100 count) with a ceiling value of $2,995.19 under a firm fixed price arrangement. The contract is not set aside and was competitively awarded by the Medical Supply Chain, a component of the Defense Logistics Agency. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for...
- The Defense Logistics Agency awarded a $1,054.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib 200 mg. The order is to be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by August 17, 2023. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order for a nonsteroidal anti-inflammatory drug is consistent with the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at two hundred ninety dollars and thirteen cents to Amerisourcebergen Drug Corporation for the supply of five hundred capsules of the pharmaceutical Celecoxib 200mg. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the products to its place of performance in Conshohocken, Pennsylvania between September 6-7, 2023. The Defense Logistics Agency routinely issues delivery orders against various...